Overcoming Barriers to Better Outcomes

SOURCES:

Zerocancer.org: “African Americans and Prostate Cancer.”

Dana-Farber Cancer Institute: “What African American Men Need to Know About Prostate Cancer,” “Prostate cancer scoring method may underestimate mortality risk in black men.”

National Cancer Institute: “African American Men More Likely to Die from Low-Grade Prostate Cancer.”

American Cancer Society: “American Cancer Society Recommendations for Prostate Cancer Early Detection.”

European Urology: “Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.”

Memorial Sloan Kettering Cancer Center: “4 Things African American Men Should Know about Prostate Cancer.”

Moffitt Cancer Center: “Saturation Biopsy for Prostate Cancer.”

Urology: “Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?”

Prostate Cancer and Prostatic Diseases: “The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.”

Translational Urology and Andrology: “Rethinking active surveillance for prostate cancer in African American men.”

Brandon A. Mahal, MD, radiation oncologist, Dana-Farber Cancer Institute, Boston.

Lorelei Mucci, ScD, associate professor of epidemiology, Harvard School of Public Health; leader, cancer epidemiology, Dana-Farber/Harvard Cancer Center, Boston.

Kosj Yamoah, MD, PhD, radiation oncologist, Moffitt Cancer Center, Tampa, FL.